Abiopharma

Boxlight Reports Fourth Quarter and Full Year 2025 Financial Results

NYSE: MMA Conor McGregor’s Coach John Kavanagh Advances Global Coaching Syllabus

Les 10 technologies émergentes de Forrester pour 2026 : l’IA ne se limite plus aux flux de travail numériques

Performance Shipping Inc. Announces Long-Term Time Charters for Two Suezmax Newbuilding Tankers Delivering in 2028 and 2029

Inspira Completes Commercial Deployment of its AME System at a Tier-1 U.S. Defense Entity

MAIA Biotechnology Activates First U.S. Site for Ongoing International Phase 2 Expansion Trial of Novel Telomere Targeting Treatment Targeting Advanced Non-Small Cell Lung Cancer

MAIA Biotechnology Activates First U.S. Site for Ongoing International Phase 2 Expansion Trial of Novel Telomere Targeting Treatment Targeting Advanced Non-Small Cell Lung Cancer

Rosen Law Firm Encourages Bluemount Holdings Ltd. Investors to Inquire About Securities Class Action Investigation – BMHL

Tyler Technologies Publishes 2025 Corporate Responsibility Report

Illumina, Inc. - DRAGEN v4.5 supports Illuminas new TruPath Genome and 5-base assays, drives insights across germline, oncology, and multiomic workflows